Although the differential effects of UCH-L1 and UCH-L3 on CSC-like behaviors have been identified, it is essential to identify the specific targets for these two deubiquitinating enzymes to achieve a deeper understanding underlying the molecular mechanism of prostate cancer progression. This evidence concerns the gene UCHL1 and prostate cancer.